Improving cancer patients' prognosis by incorporating mindfulness intervention into the treatment strategy.
World Journal of Psychiatry May 19, 2025 DOI: 10.5498/wjp.v15.i5.102977 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Controlled trial Peer reviewed |
|---|---|
| Sample size | 110 |
| Population | Patients with urinary system tumors and depression |
| Interventions | Epirubicin Mindfulness intervention strategy |
| Topics | Meditation |
| Keywords | Cancer patient Mindfulness intervention Psychiatric distress Suicide Urinary system tumor Cancer treatment Mental health therapy Mindfulness meditation Oncology research Integrative medicine |
| Key findings | Combining epirubicin with mindfulness interventions significantly improves immune function, tumor markers, depression, quality of life, fatigue, and nursing satisfaction compared to standard care. |
Abstract
This letter discusses the study by Liu et al recently published in World Journal of Psychiatry, which examines the benefits of combining epirubicin (EPI) with mindfulness interventions for patients with urinary system tumors and depression. The study included 110 patients and compared an experimental group receiving EPI and a mindfulness intervention strategy with a control group treated with mitomycin and standard care. Results showed that the experimental group had significant improvements in immune function, tumor markers, depression severity, quality of life, cancer-related fatigue, and nursing satisfaction. Despite acknowledging the study limitations such as a relatively small sample size and a short duration, the study highlights the efficacy of integrating mindfulness interventions into cancer treatment strategies to enhance patient outcomes and address psychological distress.